BMRN — BIOMARIN PHARMACEUTICAL INC

Ownership history in Caption Management, LLC  ·  64 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in BIOMARIN PHARMACEUTICAL INC (BMRN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.97% (2020 Q1)
Avg. % of fund
0.17%
First filed
2017 Q4
Last filed
2025 Q4
Quarters held
64
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 19,500 -32,500 -62.5% 0.01% $1.2M $59.43
2025 Q3 ADDED 52,000 +40,000 +333.3% 0.02% $2.8M $54.16
2025 Q2 REDUCED 12,000 -13,500 -52.9% 0.01% $660K $54.97
2025 Q2 REDUCED 25,500 -18,000 -41.4% 0.02% $1.4M $54.97
60 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    BMRN price (monthly, adj. close)

Other funds also holding BMRN

As of 2025 Q4 — sorted by position size

Krensavage Asset Management, LLC 3Y 7Y 11.02% BOONE CAPITAL MANAGEMENT LLC 3Y 7.68% Palo Alto Investors LP 3Y 7Y 6.17% Vestal Point Capital, LP 6.06% Eagle Health Investments LP 3Y 4.79% Novo Holdings A/S 3Y 7Y 3.05% Soleus Capital Management, L.P. 3Y 2.89% SECTOR GAMMA AS 3Y 7Y 2.69% Deep Track Capital, LP 3Y 2.44% Sio Capital Management, LLC 3Y 7Y 2.18%
← Back to Caption Management, LLC Holdings